Hi [[ session.user.profile.firstName ]]

Newton Media Insight

  • Date
  • Rating
  • Views
  • WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents Gerald Murphy (BSKB), Eugene Perez (BSKB), Kristi Sawert (USPTO), Peter Scott (WIPR) Recorded: Oct 13 2016 66 mins
    Challenging patents involving unpredictable technologies for obviousness is particularly difficult due to the well-established factor of “reasonable expectation of success” and the related KSR factor of “limited number of predictable solutions”. This webinar, presented by attorneys that have successfully argued on both sides of this issue for chem/pharma/bio patents, will discuss two to three leading PTAB decisions, including related appeals, that illustrate when obviousness challenges have and have not been successful. The case discussions will provide (1) a summary of the documentary evidence relied on, including critical excerpts from that evidence, (2) a summary of the “story” that was being told by each party and (3) the role that expert testimony appeared to play in the PTAB decisions. This one-hour seminar will also briefly explore what types of cases are better challenged in court and what types of cases are better challenged at the PTAB. The goals of the seminar are to allow parties to evaluate the chances of success for a contemplated or recently filed PTAB challenge and to help parties to a PTAB proceeding develop a record to support their respective positions. CLE available.
  • WIPR and BSKB present -Disparaging marks: The Redskins, The Slants and the USPTO WIPR and BSKB present -Disparaging marks: The Redskins, The Slants and the USPTO Robert Kenney (BSKB), John Ferman (BSKB), Professor Steven D. Jamar (Howard IP Program), Peter Scott (WIPR) Recorded: May 11 2016 61 mins
    When the Federal Circuit last year effectively struck down the portion of section 2(a) of the Lanham Act that bars so-called ‘disparaging’ trademarks in the US, it paved the way for a potential Supreme Court review of the issue. In this webinar, we discuss the implications of the decision, the case that prompted it, The Redskins, The Slants and other potentially ‘disparaging’ trademarks, and the implications for US practice. Robert Kenney and John Ferman from Birch Stewart Kolasch & Birch and Professor Steven D. Jamar from the Howard IP Program are joined by Peter Scott, to consider this controversial issue. We hope you’ll join us for a lively debate.

    1-hour long

    CLE available.
  • Manage worldwide risks with GfK geodata & CRESTA zones Manage worldwide risks with GfK geodata & CRESTA zones Christopher Guider, Matthias Hauschild, Chris Ewing Recorded: Sep 3 2014 61 mins
    Intelligent Insurer is hosting a free GfK webinar on September 3 from 3-4pm BST (London time) that shows how GfK boundary data and CRESTA zones support reinsurance applications. A use case by Aon Benfield Impact Forecasting demonstrates how GfK geodata helps the company develop catastrophe models and visualize exposures, hazards and risks.

    What you’ll learn from this webinar
    * How GfK geodata supports catastrophe model development
    * Why GfK boundary data offers distinct advantages for planning and managing risk
    * The benefits of using postal boundaries and CRESTA zones as a basis of planning

    Click the “Attend” button to register for this free webinar.

    Who should attend
    * Reinsurers and reinsurance companies and brokers
    * Risk model users
    * GIS users in a (re)insurance context
    * Anyone interested in how geodata supports the full spectrum of (re)insurance tasks

    The webinar is moderated by Wyn Jenkins, the group managing editor of Intelligent Insurer, and includes presentations by Matthias Hauschild, Senior Consultant at GfK; Christopher Guider, Marketing Manager at GfK; and Chris Ewing, Catastrophe Model Developer at Aon Benfield Impact Forecasting. GfK is a leading provider of administrative, postal and CRESTA boundary data specifically designed to support reinsurance applications.

Embed in website or blog